Synergy Research Group Releases Annual 2014 Orange Paper

Share Article

Q4 Orange Paper delivers insight into the state of clinical trials in Russia in 2014

Synergy Research Group

The Synergy Orange Paper 2014 demonstrates that Russia remains an attractive option for clinical trials.

Synergy Research Group released its annual 2014 Orange Paper. The Synergy Orange Paper gives a detailed view of how clinical trials performed in 2014 as a whole. The Synergy Orange Paper has a reputation for delivering unbiased and detailed intelligence, based on data from agencies like the Ministry of Health. The report is issued quarterly, gives a strategic overview and drills down into additional data, such as the number of trials, top companies that initiated studies and their country of origin.

The Synergy Orange Paper is relied on by the life science and business community to give them actionable intelligence. The report compares current data with previous numbers so readers can see quarterly and year-over-year changes.

“Russia remains an attractive option for clinical trials,” said Igor Stefanov, CEO of Synergy Research Group. “We are very proud to publish the Orange Paper, which gives sponsors and other companies needed intelligence on the state of the industry in the region.”

Russia has large patient populations across high-demand therapeutic areas such as oncology, central nervous system and cardiovascular. The region is known for high study completion rate and a pool of experienced researchers. The region’s centralized healthcare system makes it easier to recruit and retain patients involved in clinical studies. The per-patient spend on pharmaceuticals is expected to more than double by 2016, growing to over four billion dollars annually.

“We work with agencies like the Russian Ministry of Health to gather the data needed for the Synergy Orange Paper,” Stefanov continued. “Looking at the current state of clinical trials and how it compares to past years gives readers insights that they can use to make strategic decisions.”

Synergy Research Group leads the Russian market in full-service contract research. The company has senior management teams with deep domain expertise, as well as executives with experience working inside regulatory agencies who speed the approval processes. The company recently released the Synergy Ukraine Orange Paper, which gives clinical trial data gleaned as a result of an agreement with the Ukrainian Ministry of Health.

About Synergy Research Group
Synergy Research Group, http://www.synergycro.ru , is a full-service Contract Research Organization (CRO) founded in 2002 that delivers its Troika Promise of Speed, Cost and Quality to clients. Synergy provides a full range of CRO services to help global pharmaceutical and biotechnology companies conduct successful and cost-effective clinical trials. The company provides transparency, access and control to sponsors during the entire project through its cloud-based monitoring system. Synergy has locations in Moscow, Saint-Petersburg, Novosibirsk, Yekaterinburg, Perm, Krasnodar, Almaty and Astana (Kazakhstan) and Kyiv (Ukraine). The company's headquarters are in Moscow.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Leslie Proctor
Springboard5 Marketing
(801) 208-1100
Email >
Visit website